# PET Imaging of PARP Activity in Cancer

> **NCT02469129** · EARLY_PHASE1 · UNKNOWN · sponsor: **Washington University School of Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** [18F]FluorThanatrace

## Key facts

- **NCT ID:** NCT02469129
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2024-07
- **Final completion:** 2025-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469129, "PET Imaging of PARP Activity in Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02469129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*